The in vitro Antitumour Activity of Substituted Dibutyl-1,3,2-dioxastannolanes
β Scribed by S. C. Ng; Peter G. Parsons; K. Y. Sim; Carolyn J. Tranter; Rodney H. White; David J. Young
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 128 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0268-2605
No coin nor oath required. For personal study only.
β¦ Synopsis
Six dibutyl-1,3,2-dioxastannolanes, including two enantiomeric pairs, exhibited greater in vitro antitumour activity towards a variety of human tumour cell lines than cisplatin but with little discrimination, suggesting hydrolysis to a common cytotoxic intermediate. A cell line hypersensitive to mitochondrial inhibitors (CI80-13S) was not sensitive to any of the test compounds, suggesting that cell mechanisms other than, or in addition to, mitochondrial function are targeted by tin antitumour agents. A pigmented melanoma cell line (MM418c5) was resistant to the test compounds, which were found to be sequestered by melanin. This resistance was not observed with triphenyltin hydroxide.
π SIMILAR VOLUMES
Di-n-butyl-, triphenyl and tri-n-butyltin derivatives of 3S,4S-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl-4-[(R)-1-carboxyethyl]-2-azetidinone were synthesized and characterized. Their antitumour activity was screened against seven tumoural cell lines of human origin. Copyright
## Abstract BuSnCl~2~[(OPPh~2~)(SPPh~2~)N] (1) and BuSnCl[(OPPh~2~)(SPPh~2~)N]~2~ (2) were prepared by reacting BuSnCl~3~ and K[(OPPh~2~)(SPPh~2~)N], in 1:1 and 1:2 molar ratios. The compounds were investigated in solution by multinuclear (^1^H, ^13^C, ^31^P, ^119^Sn) NMR spectroscopy. Variableβtem